Skip to main content
Caplight Logo









Sable Bio

Sable Bio

Private
LondonHealthcare & Life Scienceshttps://sablebio.com/

Last Round

Seed

Feb 11, 2026

Total Funding Raised

$9.55M

Company Overview

Sable Bio is a biotechnology company that provides an AI-powered platform for drug safety assessment and target toxicology analysis in the pharmaceutical industry.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

drug discoverydrug target safetyAI drug discoverydrug safetytoxicity predictionbiotech AIclinical trial failurecausal inferencesafety intelligencein silico toxicologybiomedical data analysisSaaS platformAI for pharmatarget validation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sable Bio Comparables

Compare Sable Bio with similar companies based on industry and business-model similarity.

Sable Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
DeepCyte
80%
Inductive Bio
78%
Metisox
78%

Sable Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedFeb 11, 2026
Pre SeedFeb 6, 2024
SeedJul 14, 2022
SeedFeb 27, 2020
Pre SeedJun 9, 2019

Key People

Founding team and executive leadership

Josh Almond-Thynne

Chief Executive Officer

Executive Team

Olly Oechsle

CTO

Executive Team

Sable Bio Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 6, 2024

    $1.9M round led by Episode 1 Ventures.

Sable Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sable Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sable Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range15
Year Founded2023
Last FundingFeb 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?